Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 4. Other FLT3 inhibitors also reduce FLT3 expression. Western blot analysis of FLT3 expression in MOLM-14 cells treated with 1 μM of gilteritinib, midostaurin, crenolanib, or quizartinib for 24 h. β-Actin was used as a loading control.
Biomolecules & Therapeutics 2024;32:577~581 https://doi.org/10.4062/biomolther.2023.215
© Biomolecules & Therapeutics